Press releases are provided below as PDF files. To install the free Adobe Acrobat Reader, click below.

September 1, 2010

iBio and Fraunhofer Execute Business Development and Marketing Agreement with GE Healthcare

August 5, 2010

Arthur Y. Elliott, PhD, Joins iBio's Board of Directors

July 27, 2010

iBio Taps Pharmaceutical and Biotech Research Leader Terence E. Ryan, PhD To Drive New Business Development

June 7, 2010

Link to Video of iBio's Presentation at Noble Financial Sixth Annual Equity Conference - ONTRACK 2010

June 4, 2010

iBio to Present at Noble Financial Sixth Annual Equity Conference - ONTRACK 2010

June 3, 2010

iBio and Fraunhofer USA Center for Molecular Biotechnology Enter Agreement to Provide Global Access for Bill & Melinda Gates Foundation Vaccines

April 22, 2010

Fraunhofer Centers in Newark, DE, and at Boston University Develop Plant-Based Vaccine Factory based on Proprietary Expression Technology of iBio, Inc.

April 1, 2010

iBio Appoints Dr. Pamela Bassett to Board of Directors

March 2, 2010

iBio Appoints Vidadi Yusibov, Ph.D. Chief Scientific Officer

March 2, 2010

iBio Appoints Philip K. Russell, M.D. to Board of Directors

February 26, 2010

iBio, Inc. Announces Agreement in Principle for Licensing Large-Scale Vaccine Production Facility Using Green Plant Technology

October 12, 2009

iBio to Present Advantages of Plant-Based Vaccine Manufacturing at International Association for Biologicals Conference

September 14, 2009

Frederick Larcombe Appointed Chief Financial Officer of iBio

September 10, 2009

iBio Completes $3 Million Private Placement

August 14, 2009

iBioPharma, Inc. Changes Its Name To iBio, Inc.